| Mosa Meat B.V.. (2/23/21). "Press Release: Mosa Meat Completes $85m Series B Investment Round". Maastricht. |
2021-02-23 |
| InteRNA Technologies B.V.. (2/16/21). "Press Release: InteRNA Technologies Announces Dosing of First Patient in First-in-Human Trial of microRNA Drug Candidate INT-1B3 in Patients with Advanced Solid Tumors". Utrecht. |
2021-02-16 |
| Forbion Capital Partners. (2/10/21). "Press Release: Launch of Novel Gene Therapy Company, VectorY, to Develop Innovative Vectorized Antibodies". Amsterdam. |
2021-02-10 |
| Galapagos N.V.. (2/10/21). "Press Release: Galapagos and Gilead Discontinue ISABELA Phase 3 Trials in IPF". Foster City, CA & Mechelen. |
2021-02-10 |
| Pan Cancer T B.V.. (2/8/21). "Press Release: Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center". |
2021-02-08 |
| Pharvaris N.V.. (2/4/21). "Press Release: Pharvaris Announces Pricing of Upsized Initial Public Offering". Zug. |
2021-02-04 |
| Argenx SE. (2/4/21). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda. |
2021-02-04 |
| V-Bio Ventures. (2/4/21). "Press Release: First Closing of V-Bio Fund 2 Is Announced at EUR 78 Million". Ghent. |
2021-02-04 |
| Hyloris Pharmaceuticals S.A.. (2/3/21). "Press Release: Hyloris Appoints Marieke Vermeersch as VP of Investor Relations and Corporate Communications". Liège. |
2021-02-03 |
| Argenx SE. (2/2/21). "Press Release: Argenx Raises $1.0 Billion in Gross Proceeds in a Global Offering". Breda. |
2021-02-02 |
| Nyxoah S.A.. (2/2/21). "Press Release: Nyxoah and Vanderbilt University Enter Exclusive Licensing Agreement Regarding Next Generation Neurostimulation Technologies to Treat Obstructive Sleep Apnea (OSA)". Mont-Saint-Guibert. |
2021-02-02 |
| Merus N.V.. (1/21/21). "Press Release: Merus Announces Pricing of Public Offering of Common Shares". Utrecht & Cambridge, MA. |
2021-01-21 |
| Life Sciences Partners (LSP). (1/20/21). "Press Release: LSP Leads EUR 21 Million Series B Funding Round in Neurent Medical". Amsterdam. |
2021-01-20 |
| Forbion Capital Partners. (1/19/21). "Press Release: Forbion Invests USD 2.3M in Seed Financing of CoviCept Therapeutics, Inc.". Naarden. |
2021-01-19 |
| Merus N.V.. (1/19/21). "Press Release: Merus N.V. Announces Proposed Public Offering of Common Shares". Utrecht & Cambridge, MA. |
2021-01-19 |
| Merus N.V.. (1/19/21). "Press Release: Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies". Indianapolis, IN & Utrecht. |
2021-01-19 |
| Thermo Fisher Scientific Inc.. (1/15/21). "Press Release: Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep". Waltham, MA & Lyon. |
2021-01-15 |
| NewAmsterdam Pharma B.V.. (1/14/21). "Press Release: NewAmsterdam Pharma Completes $196M (€160M) Series A Funding for Comprehensive Phase 3 Development Program". Naarden. |
2021-01-14 |
| UCB S.A.. (1/13/21). "Press Release: UCB Announces Launch of Nile AI, Inc., a Digital Health Company Set to Transform the Course of Epilepsy". Brussels & Atlanta, GA. |
2021-01-13 |
| Life Sciences Partners (LSP). (1/12/21). "Press Release: LSP and Philip Scheltens Launch New, Unique Fund to Fight Dementia". Amsterdam. |
2021-01-12 |
| Qiagen N.V.. (1/8/21). "Press Release: Qiagen Announces Appointment of New Supervisory Board Member". Venlo. |
2021-01-08 |
| BioGeneration Ventures B.V.. (1/7/21). "Press Release: BioGeneration Ventures BGV IV Fund Closes at €140 Million". Naarden. |
2021-01-07 |
| Merus N.V.. (1/7/21). "Press Release: Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers". Utrecht & Cambridge, MA. |
2021-01-07 |
| Argenx SE. (1/6/21). "Press Release: Argenx and Zai Lab Announce Strategic Collaboration for Efgartigimod in Greater China". Breda, Shanghai & San Francisco, CA. |
2021-01-06 |
| Cristal Delivery B.V. (d/b/a Cristal Therapeutics). (1/6/21). "Press Release: Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms". Bilthoven & Maastricht. |
2021-01-06 |
| Argenx SE. (1/4/21). "Press Release: Argenx to Present at 39th Annual J.P. Morgan Healthcare Conference". Breda & Ghent. |
2021-01-04 |
| Uniqure N.V.. (12/21/20). "Press Release: uniQure Announces Clinical Update on Hemophilia B Gene Therapy Program". Lexington, MA & Amsterdam. |
2020-12-21 |
| Univercells S.A.. (12/17/20). "Press Release: Univercells Holding Raises €70 Million in Series C Financing". Brussels. |
2020-12-17 |
| Galapagos N.V.. (12/15/20). "Press Release: Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca (filgotinib)". Foster City, CA & Mechelen. |
2020-12-15 |
| Forbion Capital Partners. (12/8/20). "Press Release: Forbion Secures EUR 460 Million for Oversubscribed Fifth Fund". Naarden & Munich. |
2020-12-08 |
| Centogene N.V.. (12/8/20). "Press Release: Centogene and Alnylam Pharmaceuticals Launch a New Clinical Program Aimed at Revolutionizing the Diagnosis of Hereditary Transthyretin-Related Amyloidosis (“ATTRv”)". Cambridge, MA, Rostock, Berlin & Munich. |
2020-12-08 |
| Mosa Meat B.V.. (12/7/20). "Press Release: Mosa Meat Backed by Leading Global Impact Investors, Bringing Oversubscribed Round to $75M". Maastricht. |
2020-12-07 |
| Atbtherapeutics. (12/1/20). "Press Release: Atbtherapeutics Initiates Agreement with iBio CDMO to Manufacture Game-changer atbodies to Better Treat Cancer". Marche-en-Famenne. |
2020-12-01 |
| Innatera Nanosystems B.V.. (11/25/20). "Press Release: Innatera Raises €5M to Bring Neuromorphic Intelligence to the Sensor-edge". Delft. |
2020-11-25 |
| Galapagos N.V.. (11/23/20). "Press Release: Selvita to Acquire Fidelta from Galapagos". Mechelen & Krakow. |
2020-11-23 |
| Novalis Biotech. (11/23/20). "Press Release: Novalis Biotech Announces First Closing of Its Second Healthcare Fund. €8 Million Raised for Novalis Biotech Acceleration Fund". Ghent. |
2020-11-23 |
| Pharvaris B.V.. (11/18/20). "Press Release: Pharvaris Announces $80 Million Series C Financing to Advance Novel Oral Bradykinin-B2-Receptor Antagonists for the Treatment of HAE". Zug. |
2020-11-18 |
| BioCheck B.V.. (11/17/20). "Press Release: BioChek Group Announces Thomas Struckmeyer as New CEO". Reeuwijk. |
2020-11-17 |
| OncoDNA S.A.. (11/17/20). "Press Release: Successful Friendly Takeover Bid Initiated by OncoDNA on IntegraGen’s Shares". |
2020-11-17 |
| Lead Pharma Holding B.V.. (11/16/20). "Press Release: Lead Pharma Enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases". |
2020-11-16 |
| UCB S.A.. (11/12/20). "Press Release: UCB Strengthens Its Gene Therapy Activities with Additional Pipeline Programs, Capabilities and Platforms". Brussels. |
2020-11-12 |
| Apaxen S.A.. (11/12/20). "Press Release: Belgian Biotech Apaxen Appoints Bart Wuurman as CEO". Gosselies. |
2020-11-12 |
| Pharming Group N.V.. (11/09/20). "Press Release: Pharming Appoints Jeroen Wakkerman as Chief Financial Officer". Leiden. |
2020-11-09 |
| Galapagos N.V.. (11/5/20). "Press Release: OncoArendi and Galapagos Enter into Exclusive Collaboration on Chitinase Inhibitors in Fibrosis". Mechelen & Warsaw. |
2020-11-05 |
| The Protein Brewery B.V.. (11/3/20). "Press Release: The Protein Brewery Raises € 22 Million Series A investment". Breda. |
2020-11-03 |
| CytoSmart Technologies B.V.. (11/3/20). "Press Release: CytoSmart Announces the Launch of Its First Fluorescence Live-cell Imager Lux3 FL". Eindhoven. |
2020-11-03 |
| EuropaBio. (11/2/20). "Press Release: EuropaBio Announces Dr Claire Skentelbery as New Director General of the Association". Brussels. |
2020-11-02 |
| Kiadis Pharma N.V.. (11/2/20). "Press Release: Sanofi Offers to Acquire Kiadis for €308 Million". Paris & Amsterdam. |
2020-11-02 |
| Centogene N.V.. (10/20/20). "Press Release: Centogene Announces Leadership Transition". Cambridge, MA & Rostock. |
2020-10-20 |
| Atbtherapeutics. (10/20/20). "Press Release: Atbtherapeutics Strengthens Its Scientific Advisory Board to Support the Development of its Novel Platform and Portfolio". Belgium. |
2020-10-20 |
| ProteoNic B.V.. (10/20/20). "Press Release: ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics". Leiden. |
2020-10-20 |
| Galapagos N.V.. (10/15/20). "Press Release: Galapagos and Servier Report Topline Results for ROCCELLA Phase 2 Clinical Trial with GLPG1972/S201086 in Knee Osteoarthritis Patients". Mechelen & Paris. |
2020-10-15 |
| Qiagen N.V.. (10/13/20). "Press Release: Qiagen Reports Strong Preliminary Results for Third Quarter of 2020". Venlo. |
2020-10-13 |
| Oxurion N.V.. (10/13/20). "Press Release: Oxurion NV Appoints Tom Graney, CFA as Chief Financial Officer". Leuven & Boston, MA. |
2020-10-13 |
| Argenx SE. (10/6/20). "Press Release: Argenx Expands Capabilities In Antibody Engineering Through Key Technology Partnerships". Breda & Ghent. |
2020-10-06 |
| Biocartis Group N.V.. (10/6/20). "Press Release: Biocartis Announces Market Release of SeptiCyte RAPID Test on Idylla". Mechelen. |
2020-10-06 |
| Bone Therapeutics S.A.. (10/5/20). "Press Release: Bone Therapeutics, Link Health and Pregene to Develop and Commercialize the ALLOB Allogeneic Bone Cell Therapy Platform in China and Southeast Asia". Gosselies. |
2020-10-05 |
| Qiagen N.V.. (10/5/20). "Press Release: Qiagen to Complement COVID-19 Testing Portfolio with Novel Kit that Simplifies and Accelerates PCR Analysis for Research Applications". Hilden & Germantown, MD. |
2020-10-05 |
| Centre for Research on Multinational Corporations (SOMO). (10/2/20). "Press Release: New Research Reveals Large-scale Tax Avoidance by Coronavirus Test Manufacturer Qiagen". |
2020-10-02 |
| Biocartis Group N.V.. (9/30/20). "Press Release: Biocartis Receives EUR 1.2 Million Grant for Development of Highly Innovative Idylla GeneFusion Assay". Mechelen. |
2020-09-30 |
| Immatics N.V.. (9/29/20). "Press Release: Immatics Appoints Arnd Christ as Chief Financial Officer". Tübingen & Houston, TX. |
2020-09-29 |
| Mosa Meat B.V.. (9/25/20). "Press Release: Mosa Meat Raises Series B Funding to Prepare for Large-scale Cultured Meat Production". Maastricht. |
2020-09-25 |
| Salvia BioElectronics B.V.. (9/22/20). "Press Release: Salvia BioElectronics Raises EUR 26M (USD 31M) to Develop Innovative Neurostimulation Therapy for Chronic Migraine". Eindhoven. |
2020-09-22 |
| T-Knife GmbH. (9/21/20). "Press Release: T-Knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell Therapy". Berlin & Somerset, NJ. |
2020-09-21 |
| Lava Therapeutics B.V.. (9/17/20). "Press Release: Lava Therapeutics Announces $83 Million Series C Financing to Advance Novel Immuno-Oncology Programs". Utrecht & Philadelphia, PA. |
2020-09-17 |
| Qiagen N.V.. (9/17/20). "Press Release: Qiagen Fully Acquires NeuMoDx Molecular, Inc., Rounding Out Portfolio of PCR-based Diagnostic Automation Systems". Hilden & Ann Arbor, MI. |
2020-09-17 |
| InflaRx N.V.. (9/17/20). "Press Release: InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strategy Officer". Jena. |
2020-09-17 |
| Freshfields Brukhaus Deringer. (9/17/20). "Press Release: Freshfields Advises Univercells in Two Successive Equity Raising and Financing". |
2020-09-17 |
| Immatics N.V.. (9/15/20). "Press Release: Immatics Appoints Biotech Executive Eliot Forster to Board of Directors". Tübingen & Houston, TX. |
2020-09-15 |
| Atbtherapeutics. (9/9/20). "Press Release: Atbtherapeutics Appoints Dr Werner Cautreels and Dr Vincent Brichard to Its Board of Directors to Foster Development of Its Game-changing Antibody-toxin Bioengineered ‘Atbody’ Therapeutics". Belgium. |
2020-09-09 |
| Intravacc B.V.. (9/8/20). "Press Release: Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine". Bilthoven. |
2020-09-08 |
| Imcyse S.A.. (9/7/20). "Press Release: Imcyse Announces the Appointment of Denis Bedoret as Chief Executive Officer". Liège. |
2020-09-07 |
| Amarna Therapeutics B.V.. (9/3/20). "Press Release: Dutch Amarna Therapeutics Announces the Appointment of Steen Klysner as Chief Executive Officer". Leiden. |
2020-09-03 |
| EuropaBio. (9/3/20). "Press Release: Novartis’s Andrew Topen Appointed as New Chairman of EuropaBio". |
2020-09-03 |
| IME Medical Electrospinning. (9/3/20). "Press Release: IME Medical Electrospinning Secured € 3 Million in New Financing From Dutch VCs Borski Fund, Lumana Invest, TIIN Capital and From Rabobank to Further Expand its Medispin XL Production Platform". Waal |
2020-09-03 |
| Biocartis Group N.V.. (9/1/20). "Press Release: Biocartis Expands Collaboration with LifeArc". Mechelen & London. |
2020-09-01 |
| Royal Philips. (8/27/20). "Press Release: Philips to Expand Its Image-guided Therapy Devices Portfolio through Acquisition of Intact Vascular". Amsterdam. |
2020-08-27 |
| NewAmsterdam Pharma B.V.. (8/25/20). "Press Release: NewAmsterdam Pharma Acquires Obicetrapib from Amgen". Naarden. |
2020-08-25 |
| Qiagen N.V.. (8/21/20). "Press Release: Qiagen Announces New Chairman of Supervisory Board". Venlo. |
2020-08-21 |
| Galapagos N.V.. (8/19/20). "Press Release: Galapagos Announces that Gilead Received a Complete Response Letter for Filgotinib for the Treatment of Moderately to Severely Active Rheumatoid Arthritis". Mechelen. |
2020-08-19 |
| Byondis B.V.. (8/19/20). "Press Release: Byondis Announces Appointment of Chief Financial Officer". Nijmegen. |
2020-08-19 |
| Qiagen N.V.. (8/18/20). "Press Release: Qiagen Expands Integrated Coronavirus NGS and Software Solutions to Accelerate COVID-19 Research". Hilden & Germantown, MD. |
2020-08-18 |
| Qiagen N.V.. (8/13/20). "Press Release: Qiagen to Continue Successful Growth Strategy Focused on Execution and Greater Value Creation after Voluntary Public Takeover Offer Falls Short". Venlo. |
2020-08-13 |
| Galapagos N.V.. (8/12/20). "Press Release: Scipher Medicine and Galapagos Sign Collaboration in Inflammatory Bowel Disease". Mechelen & Boston, MA. |
2020-08-12 |
| Saillant Therapeutics B.V.. (8/11/20). "Press Release: Dutch Saillant Therapeutics to Develop Generic Virus Inhibiting Therapy Based on Activation of a Cellular Master Regulator, Ending Virus Replication". Nijmegen. |
2020-08-11 |
| GlaxoSmithKline plc. (7/31/20). "Press Release: Sanofi and GSK Selected for Operation Warp Speed to Supply United States Government with 100 Million Doses of COVID-19 vaccine". London & Paris. |
2020-07-31 |
| GlaxoSmithKline plc. (7/31/20). "Press Release: Sanofi and GSK in Advanced Discussions with European Union to Supply up to 300 Million Doses of COVID-19 Vaccine". London & Paris. |
2020-07-31 |
| Vico Therapeutics B.V.. (7/29/20). "Press Release: Biotech Vico Therapeutics Raises $31 Million (€27 Million) in Series A Financing Round to Advance Therapies for Rare Central Nervous System Diseases". Leiden. |
2020-07-29 |
| Wacker Chemie AG. (7/28/20). "Press Release: Wacker Invests in Amsterdam Biotech Site". Munich & Amsterdam. |
2020-07-28 |
| ExeVir Bio B.V.. (7/28/20). "Press Release: ExeVir Bio to Accelerate Development of New Treatment Conferring Broad Protection Against COVID-19. EUR23M Series A Financing to Advance Lead Novel Llama-derived Antibody into Clinical Trials". Leuven. |
2020-07-28 |
| Citryll B.V.. (7/21/20). "Press Release: Industry Veterans Paul Peter Tak and Eric Meldrum Join Citryll’s Board". Oss. |
2020-07-21 |
| Qiagen N.V.. (7/16/20). "Press Release: Thermo Fisher Scientific and Qiagen N.V. Agree on Amended Terms to Acquisition Agreement". Waltham, MA & Venlo. |
2020-07-16 |
| Kiadis Pharma N.V.. (7/13/20). "Press Release: Kiadis Appoints Ray Barlow, Ph.D. as Chief Business Officer and Govert Schouten, Ph.D. as Head of Innovation to Kiadis Management Team". Amsterdam. |
2020-07-13 |
| Forbion Capital Partners. (7/9/20). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund at EUR 185 million (USD 208 million)". Naarden & Munich. |
2020-07-09 |
| Belgian Growth Fund. (7/9/20). "Press Release: Final Closing Belgian Growth Fund at 312 Million Euro". |
2020-07-09 |
| OncoDNA S.A.. (7/9/20). "Press Release: Agreement to File a Friendly Takeover Bid Initiated by OncoDNA on IntegraGen to Acquire All Outstanding Shares at a Price of 2.20€ per Share". Gosselies & Evry. |
2020-07-09 |
| VarmX B.V.. (7/8/20). "Press Release: VarmX Raises €32 million in Series B Financing to Develop Innovative Reversal Agent for the Treatment and Prevention of Severe Bleeding in Patients on Oral Anticoagulants". Leiden. |
2020-07-08 |
| Kiadis Pharma N.V.. (7/8/20). "Press Release: Kiadis Licenses Previously Undisclosed Pre-clinical K-NK-cell Programs to Sanofi, with Total Potential Deal Value of €875 Million, plus Royalties". Amsterdam. |
2020-07-08 |
| Immatics N.V.. (7/2/20). "Press Release: Immatics Announces Completion of Business Combination and Listing on NASDAQ". Houston, TX & Tübingen. |
2020-07-02 |
| S-Biomedic N.V.. (7/2/20). "Press Release: S-Biomedic Is Gearing Up for Significant Growth and Has Appointed a New CCO". Beerse. |
2020-07-02 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 11 12 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
